Intellectual Property Cases
Cases 11 - 20 of 295
RSS Feed | View as table | Sort by filed date
Merck Sharp & Dohme Corp. et al v. Actavis Laboratories FL, Inc. et al
as 1:2020cv20217
Defendant: Teva Pharmaceuticals USA, Inc., Actavis Laboratories FL, Inc. and Actavis Pharma, Inc.
Plaintiff: MSD Investment Holdings (Ireland), Optimer Pharmaceuticals LLC, Merck Sharp & Dohme Corp. and others
Cause Of Action: 15 U.S.C. § 1126
ELI LILLY AND COMPANY v. ACTAVIS LLC et al
as 1:2017cv00982
Defendant: ACTAVIS LLC, TEVA PHARMACEUTICALS USA, INC. and TEVA PHARMACEUTICAL INDUSTRIES LTD.
Plaintiff: ELI LILLY AND COMPANY
Cause Of Action: 35 U.S.C. § 145
Merck Sharp & Dohme Corp. et al v. Actavis Laboratories FL, Inc. et al
as 0:2020cv60110
Defendant: Teva Pharmaceuticals USA, Inc., Actavis Laboratories FL, Inc. and Actavis Pharma, Inc.
Plaintiff: MSD Investment Holdings (Ireland), Optimer Pharmaceuticals LLC, Merck Sharp & Dohme Corp. and others
Cause Of Action: 15 U.S.C. § 1126
MERK SHARP & DOHME CORP. et al v. ACTAVIS LABORATORIES FL, INC. et al
as 2:2020cv00533
Defendant: TEVA PHARMACEUTICALS USA, INC., ACTAVIS LABORATORIES FL, INC. and ACTAVIS PHARMA, INC.
Plaintiff: MSD INVESTMENT HOLDINGS (IRELAND), OPTIMER PHARMACEUTICALS LLC, MSD INTERNATIONAL GMBH and others
Cause Of Action: 15 U.S.C. § 1126
Noven Pharmaceuticals, Inc. v. Actavis Laboratories UT, Inc.
as 1:2018cv00758
Defendant: Actavis Laboratories UT, Inc.
Plaintiff: Noven Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
CyDex Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. et al
as 1:2017cv01832
Defendant: Teva Pharmaceuticals USA, Inc., Actavis LLC and Teva Pharmaceutical Industries Ltd.
Plaintiff: CyDex Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Shire Development LLC et al v. Teva Pharmaceuticals USA, Inc. et al We have downloadable decisions or orders for this case
as 1:2017cv01696
Plaintiff: Shire LLC, Shire US Inc. and Shire Development LLC
Defendant: Teva Pharmaceuticals Industires Limited, Actavis Laboratories FL, Inc., Teva Pharmaceuticlas USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271
BAUSCH HEALTH COMPANIES INC. et al v. ACTAVIS LABORATORIES FL, INC. et al
as 2:2019cv13722
Defendant: TEVA PHARMACEUTICALS USA, INC., ACTAVIS LLC, ACTAVIS LABORATORIES FL, INC. and others
Plaintiff: PROGENICS PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, INC., WYETH LLC and others
Cause Of Action: 35 U.S.C. § 271
UCB, Inc. et al v. Actavis Laboratories UT, Inc. We have downloadable decisions or orders for this case
as 1:2019cv00474
Plaintiff: UCB Pharma GmbH, UCB, Inc. and LTS Lohmann Therapie-Systeme AG
Defendant: Actavis Laboratories UT, Inc.
Cause Of Action: 35 U.S.C. § 271
Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al
as 1:2018cv01895
Defendant: Teva Pharmaceuticals USA, Inc., Actavis Laboratories FL, Inc. and Teva Pharmaceutical Industries Ltd.
Plaintiff: Duchesnay Inc.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?